Wei‐Zen Wei
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 48
- Immunotherapy and Immune Responses 41
- T-cell and B-cell Immunology 20
- Immune Cell Function and Interaction 14
- Oncology 34
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 11
- HER2/EGFR in Cancer Research 6
- Co-authors
- Marie P. Piechocki (9 shared papers)Shari A. Pilon (6 shared papers)Yi-chi M. Kong (7 shared papers)Jennifer B. Jacob (14 shared papers)Anne Galy (3 shared papers)Guido Ferlazzo (2 shared papers)Gerald P. Morris (1 shared paper)Joyce Reyes (8 shared papers)
- Journals
- Cancer Research (12 papers)The Journal of Immunology (9 papers)Cancer Immunology Immunotherapy (8 papers)Journal of Immunological Methods (5 papers)Cellular Immunology (3 papers)
- Partner nations
- United StatesItalySweden
In The Last Decade
Wei‐Zen Wei
69 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 94
- Immunology 1.3k
- Oncology 779
- Radiology, Nuclear Medicine and Imaging 368
- Cancer Research 169
- Biotechnology 92
Countries citing papers authored by Wei‐Zen Wei
This map shows the geographic impact of Wei‐Zen Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Zen Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Zen Wei more than expected).
Fields of papers citing papers by Wei‐Zen Wei
This network shows the impact of papers produced by Wei‐Zen Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Zen Wei. The network helps show where Wei‐Zen Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Zen Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 140 | |
| 2 | 2003 | 95 | |
| 3 | 2003 | 95 | |
| 4 | 1999 | 91 | |
| 5 | 2005 | 84 | |
| 6 | 2018 | 81 | |
| 7 | 2018 | 73 | |
| 8 | 2006 | 66 | |
| 9 | 2001 | 62 | |
| 10 | 2001 | 61 | |
| 11 | 2000 | 57 | |
| 12 | 2005 | 52 | |
| 13 | 2010 | 46 | |
| 14 | 2003 | 46 | |
| 15 | 2006 | 45 | |
| 16 | 2015 | 44 | |
| 17 | 2008 | 41 | |
| 18 | 2003 | 38 | |
| 19 | 2010 | 35 | |
| 20 | 2009 | 35 |
About Wei‐Zen Wei
Wei‐Zen Wei is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 69 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (41 papers), Monoclonal and Polyclonal Antibodies Research (22 papers), T-cell and B-cell Immunology (20 papers), Immune Cell Function and Interaction (14 papers), Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (11 papers), Glycosylation and Glycoproteins Research (7 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (779 citations), Radiology, Nuclear Medicine and Imaging (368 citations), Cancer Research (169 citations) and Biotechnology (92 citations). Wei‐Zen Wei has collaborated with scholars based in United States, Italy and Sweden. Frequent co-authors include Marie P. Piechocki, Shari A. Pilon, Yi-chi M. Kong, Jennifer B. Jacob, Anne Galy, Guido Ferlazzo, Gerald P. Morris, Joyce Reyes, Ye-Shih Ho and Richard F. Jones. Their work appears in journals such as Cancer Research, The Journal of Immunology, Cancer Immunology Immunotherapy, Journal of Immunological Methods and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.